共 192 条
[1]
Wang Y(2016)Racial differences in six major subtypes of melanoma: descriptive epidemiology BMC Cancer 16 691-289
[2]
Zhao Y(2016)Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66 271-670
[3]
Ma S(2018)Long-term survival with modern therapeutic agents against metastatic melanoma—vemurafenib and ipilimumab in a daily life setting Med Oncol 35 24-74
[4]
Miller KD(2015)Gaining momentum: new options and opportunities for the treatment of advanced melanoma Cancer Treat Rev 41 660-1457
[5]
Siegel RL(2014)Therapy preferences in melanoma treatment - willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls PLoS One 9 e111237-127
[6]
Lin CC(2014)Shared decision making in dermato-oncology: preference for involvement of melanoma patients Melanoma Res 24 68-1151
[7]
Mariotto AB(2009)Psychological responses and coping strategies among patients with malignant melanoma Arch Dermatol 145 1453-2760
[8]
Kramer JL(2009)Decision making and quality of life in the treatment of cancer: a review Support Care Cancer 17 117-421
[9]
Rowland JH(2010)Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review Ann Oncol 21 1145-983
[10]
Stein KD(2017)Cancer patients’ control preferences in decision making and associations with patient-reported outcomes: a prospective study in an outpatient cancer center Support Care Cancer 25 2753-4917